N-methyl-D-aspartic Acid (NMDA) and Cognitive Remediation in Schizophrenia

NCT01474395 · clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
16
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Nathan Kline Institute for Psychiatric Research

Collaborators